ENDOGYN
Annual accounts 2025
micro format, filed on 17-06-2026, 44 days before the deadlineTurnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €270,000. Estimated: probably between €180,000 and €410,000.
Balance sheet
balance sheet total €135,342 on 31-12-2025in euro
in euro
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
135,342 | 44,716 | |
21/28 |
13,935 | 9,658 | |
22/27 |
13,935 | 9,658 | |
24 |
7,333 | 9,658 | |
26 |
6,602 | - | |
29/58 |
121,408 | 35,058 | |
54/58 |
62,718 | 10,196 | |
490/1 |
58,689 | 24,862 | |
| Balance sheet: equity and liabilities | |||
10/49 |
135,342 | 44,716 | |
10/15 |
102,296 | 25,600 | |
10/11 |
100 | 100 | |
14 |
102,196 | 25,500 | |
17/49 |
33,046 | 19,115 | |
42/48 |
32,893 | 18,962 | |
44 |
101 | 628 | |
440/4 |
101 | 628 | |
45 |
24,858 | 6,693 | |
450/3 |
22,325 | 6,693 | |
454/9 |
2,533 | - | |
47/48 |
7,934 | 11,641 | |
492/3 |
153 | 153 | |
| Income statement | |||
9900 |
106,241 | 33,114 | |
630 |
6,121 | 342 | |
640/8 |
893 | 387 | |
9901 |
99,226 | 32,384 | |
65/66B |
206 | 191 | |
65 |
206 | 191 | |
9903 |
99,021 | 32,193 | |
67/77 |
22,325 | 6,693 | |
9904 |
76,696 | 25,500 | |
9905 |
76,696 | 25,500 | |
| Appropriation of the result | |||
9906 |
102,196 | 25,500 | |
14P |
25,500 | - | |
| Document | |||
The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 17-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 105,348 | 32,727 | ||
| 82,817 | 25,843 | ||
| 10,398 | 10,000 | ||
| 52,522 | - | ||
| 88,515 | 16,096 | ||
| 75.6% | 57.3% | ||
| 3.69 | 1.85 | ||
| 0.32 | 0.75 | ||
| 75.0% | 99.6% | ||
| 56.7% | 57.0% | ||
| over 100 | over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 |
|---|---|---|
| Tangible fixed assets | €10,398 | €10,000 |
| €6,121 | €342 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on ENDOGYN
The operating result for 2025 is nearly 3.1 times that of 2024.
Debt's share of the balance-sheet total falls from 42.7% to 24.4%. Equity and debt are higher.